WallStSmart

Clene Inc. (CLNN)vsProcter & Gamble Company (PG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Procter & Gamble Company generates 43358399% more annual revenue ($86.72B vs $200,000). PG leads profitability with a 19.2% profit margin vs 0.0%. PG earns a higher WallStSmart Score of 61/100 (C+).

CLNN

Avoid

22

out of 100

Grade: F

Growth: 4.7Profit: 2.5Value: 4.0Quality: 5.0

PG

Buy

61

out of 100

Grade: C+

Growth: 5.3Profit: 8.5Value: 3.3Quality: 6.0
Piotroski: 4/9Altman Z: 3.01
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLNNSignificantly Overvalued (-67.9%)

Margin of Safety

-67.9%

Fair Value

$2.46

Current Price

$5.80

$3.34 premium

UndervaluedFair: $2.46Overvalued
PGSignificantly Overvalued (-37.3%)

Margin of Safety

-37.3%

Fair Value

$107.17

Current Price

$147.09

$39.92 premium

UndervaluedFair: $107.17Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLNN1 strengths · Avg: 10.0/10
EPS GrowthGrowth
61.4%10/10

Earnings expanding 61.4% YoY

PG5 strengths · Avg: 9.2/10
Market CapQuality
$342.51B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
31.1%10/10

Every $100 of equity generates 31 in profit

Altman Z-ScoreHealth
3.0110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
23.1%8/10

Strong operational efficiency at 23.1%

Free Cash FlowQuality
$3.03B8/10

Generating 3.0B in free cash flow

Areas to Watch

CLNN4 concerns · Avg: 2.5/10
Market CapQuality
$69.61M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-1738.0%2/10

ROE of -1738.0% — below average capital efficiency

Revenue GrowthGrowth
-15.4%2/10

Revenue declined 15.4%

PG1 concerns · Avg: 2.0/10
PEG RatioValuation
4.082/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CLNN

The strongest argument for CLNN centers on EPS Growth.

Bull Case : PG

The strongest argument for PG centers on Market Cap, Return on Equity, Altman Z-Score. Profitability is solid with margins at 19.2% and operating margin at 23.1%.

Bear Case : CLNN

The primary concerns for CLNN are Market Cap, Profit Margin, Return on Equity.

Bear Case : PG

The primary concerns for PG are PEG Ratio.

Key Dynamics to Monitor

CLNN profiles as a value stock while PG is a mature play — different risk/reward profiles.

CLNN carries more volatility with a beta of 0.62 — expect wider price swings.

PG is growing revenue faster at 7.4% — sustainability is the question.

PG generates stronger free cash flow (3.0B), providing more financial flexibility.

Bottom Line

PG scores higher overall (61/100 vs 22/100), backed by strong 19.2% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Clene Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.

Procter & Gamble Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Procter & Gamble Company (P&G) is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, founded in 1837 by William Procter and James Gamble. It specializes in a wide range of personal health, consumer health, personal care, and hygiene products; these products are organized into several segments including Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine, & Family Care. Before the sale of Pringles to Kellogg's, its product portfolio also included food, snacks, and beverages.

Visit Website →

Want to dig deeper into these stocks?